Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Haberman RH, MacFarlane KA, Catron S, Samuels J, Blank RB, Toprover M, Uddin Z, Hu J, Castillo R, Gong C, Qian K, Piguet V, Tausk F, Yeung J, Neimann AL, Gulliver W, Thiele RG, Merola JF, Ogdie A, Rahman P, Chakravarty SD, Eder L, Ritchlin CT, Scher JU. Haberman RH, et al. Among authors: yeung j. BMJ Open. 2022 Dec 23;12(12):e063650. doi: 10.1136/bmjopen-2022-063650. BMJ Open. 2022. PMID: 36564123 Free PMC article.
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.
Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, Lynde CW, Papp KA, Rahman P, Rohekar S, Rosen CF, Russell AS, Vender RB, Yeung J, Ziouzina O, Zummer M. Gladman DD, et al. Among authors: yeung j. J Rheumatol. 2017 Apr;44(4):519-534. doi: 10.3899/jrheum.161473. J Rheumatol. 2017. PMID: 28604347
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study.
Jo CE, Georgakopoulos JR, Ladda M, Ighani A, Mufti A, Drucker AM, Piguet V, Yeung J. Jo CE, et al. Among authors: yeung j. J Am Acad Dermatol. 2020 Jun;82(6):1530-1532. doi: 10.1016/j.jaad.2020.02.029. Epub 2020 Feb 16. J Am Acad Dermatol. 2020. PMID: 32074486 No abstract available.
Comparative 12-week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real-world multicenter retrospective study.
Georgakopoulos JR, Lam K, Sandhu VK, Ighani A, Phung M, Piguet V, Yeung J. Georgakopoulos JR, et al. Among authors: yeung j. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e416-e418. doi: 10.1111/jdv.16366. Epub 2020 May 8. J Eur Acad Dermatol Venereol. 2020. PMID: 32176394 No abstract available.
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study [Formula: see text].
Jo CE, Georgakopoulos JR, Ladda M, Ighani A, Mufti A, Drucker AM, Piguet V, Yeung J. Jo CE, et al. Among authors: yeung j. J Cutan Med Surg. 2020 Sep/Oct;24(5):468-473. doi: 10.1177/1203475420928907. Epub 2020 May 22. J Cutan Med Surg. 2020. PMID: 32442020
Apremilast and its role in psoriatic arthritis.
Sandhu VK, Eder L, Yeung J. Sandhu VK, et al. Among authors: yeung j. G Ital Dermatol Venereol. 2020 Aug;155(4):386-399. doi: 10.23736/S0392-0488.20.06640-7. G Ital Dermatol Venereol. 2020. PMID: 33050680 Free article. Review.
1,269 results